Skip to main content
Clinical Trials/IRCT20180216038747N1
IRCT20180216038747N1
Recruiting
Phase 1

Comparison of the Effectiveness of Atropine 0.01% and 0.02% with placebo treatment on Myopia progression Prevention and Probable Side Effects on Children Aged 6-15 Years Old.

Shiraz University of Medical Sciences0 sites45 target enrollmentTBD
Conditionsmyopia.Myopia

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
myopia.
Sponsor
Shiraz University of Medical Sciences
Enrollment
45
Status
Recruiting
Last Updated
7 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
7 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • myopia \-0\.50 D to \-6\.00 D
  • Astigmatism \<\= 0\.75 D

Exclusion Criteria

  • myopic children with any ocular diseases such as cataract, glaucoma, uveitis, strabismus, history of trauma, history of any ocular surgery
  • systemic diseases

Outcomes

Primary Outcomes

Not specified

Similar Trials